الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

takeda pharmaceuticals america, inc. - lisdexamfetamine dimesylate (unii: sjt761gegs) (lisdexamfetamine - unii:h645gul8kj) - lisdexamfetamine dimesylate 10 mg - vyvanse® is indicated for the treatment of: - attention deficit hyperactivity disorder (adhd) in adults and pediatric patients 6 years and older [see clinical studies (14.1)] - moderate to severe binge eating disorder (bed) in adults [see clinical studies (14.2)] . limitations of use: - pediatric patients with adhd younger than 6 years of age experienced more long-term weight loss than patients 6 years and older [see use in specific populations (8.4)] . - vyvanse is not indicated or recommended for weight loss. use of other sympathomimetic drugs for weight loss has been associated with serious cardiovascular adverse events. the safety and effectiveness of vyvanse for the treatment of obesity have not been established [see warnings and precautions (5.2)] . vyvanse is contraindicated in patients with: - known hypersensitivity to amphetamine products or other ingredients of vyvanse. anaphylactic reactions, stevens-johnson syndrome, angioedema, and urticaria have been observed in postmarketing reports [see adve

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

mikart, inc. - dextroamphetamine sulfate (unii: jj768o327n) (dextroamphetamine - unii:tz47u051fi) - dextroamphetamine sulfate 2.5 mg

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

astrazeneca pharmaceuticals lp - atenolol (unii: 50vv3vw0ti) (atenolol - unii:50vv3vw0ti) - atenolol 25 mg

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

mckesson packaging services business unit of mckesson corporation - lorazepam (unii: o26fzp769l) (lorazepam - unii:o26fzp769l) - lorazepam 0.5 mg

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

daiichi sankyo inc. - oxycodone hydrochloride (unii: c1enj2te6c) (oxycodone - unii:cd35pmg570) - oxycodone hydrochloride 5 mg - roxybond is indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. limitations of use because of the risks of addiction, abuse, and misuse with opioids, even at recommended doses [see warnings and precautions ( 5.1 )] , reserve roxybond for use in patients for whom alternative treatment options (e.g., non-opioid analgesics or opioid combination products): - have not been tolerated or are not expected to be tolerated, - have not provided adequate analgesia or are not expected to provide adequate analgesia. roxybond is contraindicated in patients with: - significant respiratory depression [see warnings and precautions ( 5.3 )] - acute or severe bronchial asthma in an unmonitored setting or in the absence of resuscitative equipment or hypercarbia [see warnings and precautions ( 5.7 )] - known or suspected gastrointestinal obstruction, including paralytic ileus [see warnings and  precautions ( 5.11 )] - known hypersensitivity (e.g.

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

corepharma, llc - oxycodone hydrochloride (unii: c1enj2te6c) (oxycodone - unii:cd35pmg570) - oxycodone hydrochloride 5 mg

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

shionogi inc - hydrocodone bitartrate (unii: no70w886kk) (hydrocodone - unii:6yks4y3wq7) - hydrocodone bitartrate 5 mg

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

mckesson packaging services a business unit of mckesson corporation - losartan potassium (unii: 3st302b24a) (losartan - unii:jms50mpo89) - losartan potassium 25 mg

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

rxpak division of mckesson corp. - hydrocodone bitartrate (unii: no70w886kk) (hydrocodone - unii:6yks4y3wq7) - hydrocodone bitartrate 5 mg

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

corepharma, llc - molindone hydrochloride (unii: 1dws68pne6) (molindone - unii:rt3y3qmf8n) - molindone hydrochloride 5 mg